Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
[PMID: 7659181] PubMed record related to this compound for laboratory literature review
It promotes satiety and helps with blood sugar control but also slows down the entire gastrointestinal tract , leading to: Reduced peristalsis (gut contractions) Longer intestinal transit time Harder, drier stools Reduced Caloric and Fiber Intake Patients on GLP-1 medications often eat significantly less food due to appetite suppression
Pooping regularly isnt just about comfort
Managing Potential Side Effects Nausea and bloating are the two most common complaints when starting a GLP-1 treatment
By week 48, the overall average settled at 24.2%, with the 12mg participants achieving the benchmark result
Insulin resistance also affects the brain, particularly the appetite regulation centers in the hypothalamus, with patients increasing their food intake and gaining weight as they become more resistant to the appetite-suppressant effects of insulin, leptin, GLP-1, amylin, and peptide YY [Citation8,Citation22,Citation26]
